On our screens:Stocks that buy back more than they dilute
Is the price fair?
What MDT's price assumes
Medtronic trades at 22.7× earnings against 30.9× for the median Medical Devices name, cheaper than its own group.
22.7
Trailing P/E · Medical Devices median 30.9 · cheaper than the typical name in its group
- Price / sales
- 2.93
Price / sales · as of 2026-Q2
- Free cash flow yield
- 6.0%
Free cash flow yield · Medical Devices median 3.9%
- Growth the price implies
- +3.2%
Growth the price implies · The price pays for +3.2% free cash flow growth a year for a decade; the business has delivered +11% a year over the last three.
Details›
- Price / book2026-Q2
- 2.16
- Healthcare median P/E362 names
- 29.9
- Medical Devices median P/E39 names
- 30.9
- Free cash flow, trailing twelve months
- $6.13B
- Market capitalisation
- $101.9B
- 3-year revenue growth
- +6.0%
- 3-year free cash flow growth
- +11%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $100.51 |
| Its own P/E history, median | $103.73 |
| Its own P/E history, upper quartile | $114.03 |
| 52-week range | $73.75 – $103.73 |
| Today | $92.40 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry